-
2 Postari
-
1 Fotografii
-
0 Video
-
SEO la DengyueMed
-
Traieste in HongKong
-
Din hongkong
-
Studiat medicine la guangdongyaokedaxueClass of gvsg
-
Female
-
Urmarit de 0 people
Recent Actualizat
-
How does the IL-17A inhibitor secukinumab (Cosentyx) change the rules of inflammation management?In the field of immune-mediated inflammatory disease (IMID) treatment, the advent of biologic therapies has broken the limitations of traditional approaches and brought renewed hope for recovery to countless patients. As the world’s first fully human monoclonal antibody targeting interleukin-17A (IL-17A) to receive regulatory approval, secukinumab (Cosentyx) injection has demonstrated...0 Commentarii 0 Distribuiri 167 Views 0 previzualizareVă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
0 Commentarii 0 Distribuiri 79 Views 0 previzualizare
Mai multe povesti